Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
30.37
-1.24 (-3.92%)
Jul 24, 2026, 4:00 PM EDT - Market closed

Tectonic Therapeutic Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-93.04-84.04-58.02-44.65-105.43-118.84
Net Income
-83.49-74.15-57.98-42.82-105.89-119.13
Earnings Per Share
-4.46-4.05-6.83-33.76-16.34-33.36
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
236.890.59141.2428.770.28189.57
Total Debt
4.631.283.34.3416.4615.24
Net Cash (Debt)
232.26-0.69137.9424.43-16.18174.33
Net Cash Growth
-23.50%-464.71%---32.73%
Net Cash Per Share
12.41-0.0416.2519.26-8.2248.82

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-65.41-60.08-59.08-40.68-97.21-98.03
Capital Expenditures
-0.2-0.21-0.16-0.28-0.27-2.46
Free Cash Flow
-65.61-60.29-59.24-40.96-97.48-100.49
Free Cash Flow Growth
------